A Phase 1 study of the safety, tolerability, and pharmacokinetics of ALG-000184 (pevifoscorvir sodium), a novel Class E capsid assembly modulator, in healthy participants
Antiviral Therapy
@journals.sagepub.com
journals.sagepub.com/doi/10.1177/...
#chronichepatitis #infection #treatment #openaccess

This latest study shows that ROS accumulation reduces #OxidativeStress, #Nrf2, IL-6/IL-8, & activates Jak2/Stat3, leading to decreased #Inflammatory cell infiltration, opening new #therapeutic avenues for #ChronicHepatitis. #medsky

#OpenAccess: www.sciencedirect.com/science/arti...